ASC specks: a biomarker for myelodysplastic syndromes?

Affiliations

¹ Department of Hematology and Oncology, UKIM5, Medical University Innsbruck, Innsbruck, Austria; University Hospitals, Medizinische Klinik 3, Oncology, Hematology, Immunonology and Rheumatology, Bonn, Germany.
² University Hospitals, Institute of Innate Immunity, Bonn 53127, Germany; Department of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, MA, USA. Electronic address: eicke.latz@uni-bonn.de.

Editorial

Dominik Wolf et al. Lancet Haematol. 2018 Sep.

. 2018 Sep;5(9):e379-e380.

doi: 10.1016/S2352-3026(18)30113-3. Epub 2018 Jul 30.

¹ Department of Hematology and Oncology, UKIM5, Medical University Innsbruck, Innsbruck, Austria; University Hospitals, Medizinische Klinik 3, Oncology, Hematology, Immunonology and Rheumatology, Bonn, Germany.
² University Hospitals, Institute of Innate Immunity, Bonn 53127, Germany; Department of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, MA, USA. Electronic address: eicke.latz@uni-bonn.de.

No abstract available

Comment on

Assessment of ASC specks as a putative biomarker of pyroptosis in myelodysplastic syndromes: an observational cohort study.
Basiorka AA, McGraw KL, Abbas-Aghababazadeh F, McLemore AF, Vincelette ND, Ward GA, Eksioglu EA, Sallman DA, Ali NA, Padron E, Pinilla-Ibarz J, Komrokji R, Masala E, Santini V, Kosmider O, Fontenay M, Fenaux P, Sokol L, Wei S, Fridley B, List AF. Basiorka AA, et al. Lancet Haematol. 2018 Sep;5(9):e393-e402. doi: 10.1016/S2352-3026(18)30109-1. Epub 2018 Jul 30. Lancet Haematol. 2018. PMID: 30072146 Free PMC article.